Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Baylor Research Institute
mi
from
Dallas, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Arthritis & Osteoporosis Associates, LLP
mi
from
Lubbock, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Arthritis & Osteoporosis Associates, LLP
mi
from
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Mountain State Clinical Research
mi
from
Clarksburg, WV
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Mountain State Clinical Research
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Jeffrey Alper, MD Research
mi
from
Naples, FL
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Jeffrey Alper, MD Research
mi
from
Naples, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Research West Incorporated
mi
from
Kalispell, MT
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Research West Incorporated
mi
from
Kalispell, MT
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Piedmont Medical Research Associates
mi
from
Winston-Salem, NC
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Piedmont Medical Research Associates
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Austin Regional Clinic
mi
from
Austin, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Austin Regional Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Houston Medical Research
mi
from
Houston, TX
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Houston Medical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated:  12/4/2015
Colin Bayliss Research and Teaching Unit
mi
from
Victoria Park,
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) Monotherapy in Subjects With Active Psoriatic Arthritis
Status: Enrolling
Updated: 12/4/2015
Colin Bayliss Research and Teaching Unit
mi
from
Victoria Park,
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA
mi
from
Rogers, AR
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA
mi
from
Rogers, AR
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dermatology Research Associates
mi
from
Los Angeles, CA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Huntington Medical Foundation/Specialty Office
mi
from
Pasadena, CA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Huntington Medical Foundation/Specialty Office
mi
from
Pasadena, CA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Clinical Science Institute
mi
from
Santa Monica, CA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Clinical Science Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Olympian Clinical Research
mi
from
Clearwater, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Westcoast Radiology Services
mi
from
Clearwater, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Westcoast Radiology Services
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
North Florida Dermatology Associates, PA
mi
from
Jacksonville, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
North Florida Dermatology Associates, PA
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
International Dermatology Research, Inc.
mi
from
Miami, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Park Avenue Dermatology
mi
from
Orange Park, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Park Avenue Dermatology
mi
from
Orange Park, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Leavitt Medical Associates of Florida d/b/a Ameriderm Research
mi
from
Ormond Beach, FL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Leavitt Medical Associates of Florida d/b/a Ameriderm Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dundee Dermatology
mi
from
West Dundee, IL
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dundee Dermatology
mi
from
West Dundee, IL
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dawes Fretzin Dermatology Group
mi
from
Indianapolis, IN
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dawes Fretzin Dermatology Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Shondra L Smith, MD
mi
from
Lake Charles, LA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Shondra L Smith, MD
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Mount Sinai Hospital
mi
from
New York, NY
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Duke University Medical Center - Shipment Only
mi
from
Durham, NC
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Duke University Medical Center - Shipment Only
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dermatology Consulting Services
mi
from
High Point, NC
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Health Concepts
mi
from
Rapid City, SD
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Arlington Research Center
mi
from
Arlington, TX
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dermatology Treatment & Research Center, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Center for Clinical Studies
mi
from
Houston, TX
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Premier Clinical Research
mi
from
Spokane, WA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Premier Clinical Research
mi
from
Spokane, WA
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
DS Research
mi
from
Louisville, KY
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
DS Research
mi
from
Louisville, KY
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Dartmouth-Hitchcock Medical Center, Section of Dermatology
mi
from
Lebanon, NH
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Dartmouth-Hitchcock Medical Center, Section of Dermatology
mi
from
Lebanon, NH
Click here to add this to my saved trials
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated:  12/4/2015
Enverus Medical Research
mi
from
Surrey,
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
A Phase 2, Randomized, Double-blind, Placebo-controlled Study To Evaluate Safety And Efficacy Of Pf-04965842 In Subjects With Moderate To Severe Psoriasis
Status: Enrolling
Updated: 12/4/2015
Enverus Medical Research
mi
from
Surrey,
Click here to add this to my saved trials
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated:  12/7/2015
NMFF Dermatology Clinic
mi
from
Chicago, IL
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated: 12/7/2015
NMFF Dermatology Clinic
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated:  12/7/2015
NM Lake Forest Hospital/ Women's Center
mi
from
Lake Forest, IL
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated: 12/7/2015
NM Lake Forest Hospital/ Women's Center
mi
from
Lake Forest, IL
Click here to add this to my saved trials
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated:  12/7/2015
TKL research
mi
from
Fair Lawn, NJ
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated: 12/7/2015
TKL research
mi
from
Fair Lawn, NJ
Click here to add this to my saved trials
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated:  12/7/2015
University Hospitals Case Medical Center / Dept of Dermatology
mi
from
Cleveland, OH
Evaluate the Effect of Elimune Capsules
Open-Label Study to Evaluate the Effect of Elimune Capsules on Biomarkers in Patients With Plaque Psoriasis
Status: Enrolling
Updated: 12/7/2015
University Hospitals Case Medical Center / Dept of Dermatology
mi
from
Cleveland, OH
Click here to add this to my saved trials